StockNews.com assumed coverage on shares of Pulmatrix (NASDAQ:PULM – Get Rating) in a research note released on Tuesday. The firm issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright restated a buy rating and issued a $10.00 price objective on shares of Pulmatrix in a research note on Tuesday, February 7th. Pulmatrix […]